Filing Details

Accession Number:
0001315406-19-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-13 11:54:19
Reporting Period:
2019-09-12
Accepted Time:
2019-09-13 11:54:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
12208 Bio-Rad Laboratories Inc. BIO, BIOB Laboratory Analytical Instruments (3826) 941381833
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1616003 John Hertia C/O Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules CA 94547
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Bio-Rad A Common Stock Acquisiton 2019-09-12 600 $119.54 18,966 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2019-09-12 600 $139.56 19,566 No 4 M Direct
Bio-Rad A Common Stock Disposition 2019-09-12 797 $328.25 18,769 No 4 S Direct
Bio-Rad A Common Stock Disposition 2019-09-12 41 $329.00 18,728 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-09-12 600 $0.00 600 $119.54
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-09-12 600 $0.00 600 $139.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-09-10 No 4 M Direct
600 2025-09-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Bio-Rad A Common Stock 252 Indirect By Spouse
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.00 to $328.70, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The option vests in five equal annual installments beginning September 10, 2015.
  3. The option vests in five equal annual installments beginning September 11, 2016.